Answers are grounded in this paper and cite their sources.
A patient with mixed cell Hodgkin’s disease, who 13 years later presented with lymphoblastic lymphosarcoma is described. Whether this association represents a transformation of one form of lymphoreticular neoplasm to another or a new neoplastic process cannot be determined. The newer therapeutic modalities for lymphoma produce prolonged survival. It is, therefore, imperative that patients in remission, who exhibit a recurrence of adenopathy, be re-biopsied, since the optimum treatment differs for each of the lymphomas.
No takes yet. Share an insight, caveat, or question.
Mims et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: